Ivan Gergel is Chief Medical Officer and Managing Partner at New Rhein Healthcare Investors, with a history in pharmaceutical R&D and drug approvals. He is part of a team investing in healthcare and life sciences sectors.
At firms with a similar stage, sector and check size.
One email when Ivan's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckIvan Gergel is Chief Medical Officer and Managing Partner at New Rhein Healthcare Investors, with a history in pharmaceutical R&D and drug approvals. He is part of a team investing in healthcare and life sciences sectors.
New Rhein has not reported a check size. It invests at series a, series b.
Email [email protected], the firm's inbox for founders, and name Ivan in the subject. A warm intro from a founder New Rhein backed works better.
Chief Medical Officer & Managing Partner at New Rhein Healthcare Investors.
Last updated 2026-10-15. Is this you? Ask for a correction.